Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

126.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 137.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 14,457
  • Market Cap: £132.54m
  • RiskGrade: 80
  • Beta: 0.10

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
23.84% above the market average23.84% above the market average23.84% above the market average23.84% above the market average23.84% above the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
1yr Revenue Growth
55.29% below the market average55.29% below the market average55.29% below the market average55.29% below the market average55.29% below the market average
57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
12.39% below the market average12.39% below the market average12.39% below the market average12.39% below the market average12.39% below the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
1yr DPS Growth
6.46% above the market average6.46% above the market average6.46% above the market average6.46% above the market average6.46% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
57.68% below the market average57.68% below the market average57.68% below the market average57.68% below the market average57.68% below the market average
92.59% below the sector average92.59% below the sector average92.59% below the sector average92.59% below the sector average92.59% below the sector average
Price Book Ratio
21.14% below the market average21.14% below the market average21.14% below the market average21.14% below the market average21.14% below the market average
39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
0.41% above the market average0.41% above the market average0.41% above the market average0.41% above the market average0.41% above the market average
10% below the sector average10% below the sector average10% below the sector average10% below the sector average10% below the sector average
Price Chg 3m
35.06% above the market average35.06% above the market average35.06% above the market average35.06% above the market average35.06% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
15.51% above the market average15.51% above the market average15.51% above the market average15.51% above the market average15.51% above the market average
2.56% below the sector average2.56% below the sector average2.56% below the sector average2.56% below the sector average2.56% below the sector average
Momentum 20
15.41% below the market average15.41% below the market average15.41% below the market average15.41% below the market average15.41% below the market average
48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
16.69% below the market average16.69% below the market average16.69% below the market average16.69% below the market average16.69% below the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average
ROCE
72.98% above the market average72.98% above the market average72.98% above the market average72.98% above the market average72.98% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
21.27% above the market average21.27% above the market average21.27% above the market average21.27% above the market average21.27% above the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average
Forecast EPS
42.5% below the market average42.5% below the market average42.5% below the market average42.5% below the market average42.5% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
43.77% above the market average43.77% above the market average43.77% above the market average43.77% above the market average43.77% above the market average
51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average
Operating Profit Loss
24.58% above the market average24.58% above the market average24.58% above the market average24.58% above the market average24.58% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
30.00% above the market average30.00% above the market average30.00% above the market average30.00% above the market average30.00% above the market average
56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average
Cash
6.81% above the market average6.81% above the market average6.81% above the market average6.81% above the market average6.81% above the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
18.08% above the market average18.08% above the market average18.08% above the market average18.08% above the market average18.08% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Buys 1y
5.61% above the market average5.61% above the market average5.61% above the market average5.61% above the market average5.61% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
53.28% below the market average53.28% below the market average53.28% below the market average53.28% below the market average53.28% below the market average
52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average
Brokers Percent Neutral
36.09% above the market average36.09% above the market average36.09% above the market average36.09% above the market average36.09% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 126.50p
Change Today -1.00p
% Change -0.78 %
52 Week High 137.50
52 Week Low 96.00
Volume 14,457
Shares Issued 104.77m
Market Cap £132.54m
Beta 0.10
RiskGrade 80

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.74% below the market average65.74% below the market average65.74% below the market average65.74% below the market average65.74% below the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Price Trend
14.93% below the market average14.93% below the market average14.93% below the market average14.93% below the market average14.93% below the market average
15% below the sector average15% below the sector average15% below the sector average15% below the sector average15% below the sector average
Income
10.91% above the market average10.91% above the market average10.91% above the market average10.91% above the market average10.91% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Growth
32.35% below the market average32.35% below the market average32.35% below the market average32.35% below the market average32.35% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 21-Oct-2019

Time Volume / Share Price
15:55 577 @ 125.50p
11:47 7,800 @ 126.00p
10:26 3,930 @ 126.26p
08:39 900 @ 126.00p
08:39 1,250 @ 126.26p

Cello Health Key Personnel

CEO Mark Scott

Top of Page